Inventor · disambiguated record
Devan Naduthambi
Also filed as: NADUTHAMBI DEVAN
35 granted patents·15 pending applications·181 citations·filing 2011–2025
96Inventor score
Top patents by PatentIndex Score
50 records- 0197US11613546B2Substituted pyridotriazine compounds and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Mar 28, 2023·9 cites·44 claims
- 0297US10988451B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Apr 27, 2021·10 cites·21 claims
- 0396US11897892B2Substituted pyridotriazine compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Feb 13, 2024·6 cites·35 claims
- 0496US11643400B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2021·Granted May 9, 2023·4 cites·20 claims
- 0596US10703733B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jul 7, 2020·12 cites·27 claims
- 0695US11773122B2Phospholipid compounds and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Oct 3, 2023·4 cites·38 claims
- 0795US8563530B2Purine nucleoside phosphoramidateCHANG WONSUK·Filed 2011·Granted Oct 22, 2013·94 cites·28 claims
- 0893US12187734B2Substituted pyridotriazine compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Jan 7, 2025·1 cites·27 claims
- 0993US10774071B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Sep 15, 2020·7 cites·18 claims
- 1092US12091420B2SARS-COV2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Sep 17, 2024·3 cites·28 claims
- 1192US11667652B2MCL1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Jun 6, 2023·2 cites·15 claims
- 1291US10710986B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jul 14, 2020·4 cites·5 claims
- 1391US9765060B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Sep 19, 2017·13 cites·2 claims
- 1490US12410183B2Sars-cov2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2024·Granted Sep 9, 2025·1 cites·25 claims
- 1588US10040781B2Tank-binding kinase inhibitor compoundsGILEAD SCIENCES INC·Filed 2015·Granted Aug 7, 2018·3 cites·48 claims
- 1687US2025154116A1Mcl-1 inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1785US2025188089A1Substituted pyridotriazine compounds and uses thereofGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1883US11555029B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Jan 17, 2023·1 cites·9 claims
- 1982US12162844B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Dec 10, 2024·0 cites·14 claims
- 2082US12030904B2Phospholipid compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Jul 9, 2024·0 cites·18 claims
- 2181US10072001B2Tank-binding kinase inhibitor compoundsGILEAD SCIENCES INC·Filed 2015·Granted Sep 11, 2018·3 cites·30 claims
- 2281US2025197421A1Mcl1 inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2378US2025270195A1Pd-1/pd-l1 inhibitorsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 2477US12338233B2PD-1/Pd-L1 inhibitorsGILEAD SCIENCES INC·Filed 2022·Granted Jun 24, 2025·0 cites·4 claims
- 2577US12202842B2MCL1 inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Jan 21, 2025·0 cites·8 claims
- 2676US12473314B2Phospholipid compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Nov 18, 2025·0 cites·33 claims
- 2776US10221197B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Mar 5, 2019·2 cites·13 claims
- 2875US10092563B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Oct 9, 2018·2 cites·11 claims
- 2975US2024239807A1Sars-cov2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 3071US12116380B2Phospholipid compounds and methods of making and using the sameGILEAD SCIENCES INC·Filed 2022·Granted Oct 15, 2024·0 cites·18 claims
- 3170US2025034182A1Phospholipid compounds and methods of making and using the sameGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3266US11718637B2Prodrugs of 4′-C-substituted-2-halo-2′- deoxyadenosine nucleosides and methods of making and using the sameGILEAD SCIENCES INC·Filed 2021·Granted Aug 8, 2023·0 cites·34 claims
- 3366US2024226130A14'-thionucleoside analogues and their pharmaceutical useGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 3466US2024309028A1Phospholipid compounds and methods of making and using the sameGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3561US2023382940A1Antiviral compounds and methods of making and using the sameGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 3660US12269812B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Apr 8, 2025·0 cites·11 claims
- 3760US2024199676A1Antiviral compounds and methods of making and using the sameGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 3859US10253019B2Tank-binding kinase inhibitor compoundsGILEAD SCIENCES INC·Filed 2018·Granted Apr 9, 2019·0 cites·13 claims
- 3958US12110305B2Prodrugs of phosphonamide nucleotide analogues and their pharmaceutical useGILEAD SCIENCES INC·Filed 2021·Granted Oct 8, 2024·0 cites·45 claims
- 4052US10259811B2Tank-binding kinase inhibitor compoundsGILEAD SCIENCES INC·Filed 2018·Granted Apr 16, 2019·0 cites·10 claims
- 4148US2018065953A1Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
- 4248US2018305315A1Pd-1/pd-l1 inhibitorsGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 4347US10899735B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jan 26, 2021·0 cites·9 claims
- 4447US2025276979A1Sars-cov2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 4545US10479770B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2017·Granted Nov 19, 2019·0 cites·13 claims
- 4645US2025296936A1Sars-cov2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 4741US10214519B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2017·Granted Feb 26, 2019·0 cites·20 claims
- 4840US11021467B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Jun 1, 2021·0 cites·17 claims
- 4938US10316049B2Tank-binding kinase inhibitor compoundsGILEAD SCIENCES INC·Filed 2016·Granted Jun 11, 2019·0 cites·59 claims
- 5038US2012202794A1CompoundsSOFIA MICHAEL JOSEPH·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Devan Naduthambi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →